Your browser doesn't support javascript.
loading
2022 update to the position statement by Primary Care Diabetes Europe: a disease state approach to the pharmacological management of type 2 diabetes in primary care.
Seidu, S; Cos, X; Brunton, S; Harris, S B; Jansson, S P O; Mata-Cases, M; Neijens, A M J; Topsever, P; Khunti, K.
Affiliation
  • Seidu S; Diabetes Research Centre, University of Leicester, Leicester General Hospital, Gwendolen Road, Leicester, LE5 4PW, United Kingdom. Electronic address: sis11@le.ac.uk.
  • Cos X; Sant Marti de ProvenÒ«als Primary Care Centres, Institut Català de la Salut, University Research Institute in Primary Care (IDIAP Jordi Gol), Barcelona, Spain.
  • Brunton S; Primary Care Metabolic Group, Winnsboro, SC, USA.
  • Harris SB; Department of Family Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
  • Jansson SPO; School of Medical Sciences, University Health Care Research Centre, Örebro University, Örebro, Sweden.
  • Mata-Cases M; La Mina Primary Care Centre, Institut Català de la Salut, University Research Institute in Primary Care (IDIAP Jordi Gol), CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain.
  • Neijens AMJ; Praktijk De Diabetist, Nurse-Led Case Management in Diabetes, QOL-consultancy, Deventer, The Netherlands.
  • Topsever P; Department of Family Medicine, Acibadem Mehmet Ali Aydinlar University School of Medicine, Kerem Aydinlar Campus, 34752 Atasehir, Istanbul, Turkey.
  • Khunti K; Diabetes Research Centre, University of Leicester, Leicester General Hospital, Gwendolen Road, Leicester, LE5 4PW, United Kingdom.
Prim Care Diabetes ; 16(2): 223-244, 2022 04.
Article de En | MEDLINE | ID: mdl-35183458
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Diabète de type 2 / Hyperglycémie Type d'étude: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Limites: Humans Pays/Région comme sujet: Europa Langue: En Journal: Prim Care Diabetes Sujet du journal: ENDOCRINOLOGIA Année: 2022 Type de document: Article Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Diabète de type 2 / Hyperglycémie Type d'étude: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Limites: Humans Pays/Région comme sujet: Europa Langue: En Journal: Prim Care Diabetes Sujet du journal: ENDOCRINOLOGIA Année: 2022 Type de document: Article Pays de publication: Royaume-Uni